Lung transplantation: Potentials and limitations;Lungentransplantation: Möglichkeiten und grenzen

Internist

Volumn 45, Issue 11, 2004, Pages 1246-1260

  Gottlieb, J ^a   Welte, T ^a   Hoper M M ^a   Struber M ^a   Niedermeyer, J ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Krankenhaus Bad Oeynhausen   (Germany)

Author keywords

Heart lung transplantation; Lung transplantation; Patient selection; Pulmonary diseases; Rejection

Indexed keywords

CYSTIC FIBROSIS; EMPHYSEMA; EUROPE; EXERCISE TOLERANCE; FIBROSIS; HUMAN; LUNG DISEASE; LUNG TRANSPLANTATION; MEDICAL PRACTICE; MORTALITY; POPULATION RESEARCH; QUALITY OF LIFE; REVIEW; SURVIVAL;

COMORBIDITY; EUROPE; GRAFT REJECTION; HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 11144322065     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-004-1292-6     Document Type: Review

References (28)

1. Gabbay E, Williams TJ, Griffiths AP, Macfarlane LM, KotsimbosTC, Esmore DS, Snell GI (1999) Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med 160: 265-271
2. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI (2004) The registry of the International Society for Heart and Lung Transplantation: Twenty-first official adult lung and heart-lung transplant report - 2004. J Heart Lung Transplant 23: 804-815
3. Maurer JR, Frost AE, Estenne M, Higenbottam T, Glanville AR (1998) International guidelines for the selection of lung transplant candidates. J Heart Lung Transplant 17: 703-709
4. Liou TG, Adler FR, Cahill BC, FitzSimmons SC, Huang D, Hibbs JR, Marshall BC (2001 ) Survival benefit of lung transplantation among patients with cystic fibrosis. JAMA 286: 2683-2689
5. Charman SC, Sharples LD, McNeil KD, Wallwork J (2002) Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 21: 226-232
6. Meyer DM, Bennett LE, Novick RN, Hosenpud JD (2001) Single vs bilateral, sequential lung transplantation for end-stage emphysema: influence of recipient age on survival and secondary endpoints. J Heart Lung Transplant 20: 935-941
7. Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RN (1998) Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 351: 24-27
8. Schwaiblmaier M (1999) Cardiopulmonary exercise testing before and after lung and heart-lung-transplantation. Am J Respir Crit Care Med 159: 1277-1283
9. Kazerooni EA, Martinez FJ, Flint A et al. (1997) Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis. AJR Am J Roentgenol 169: 977-983
10. Bernard S, Whittom F, LeBlanc P (1999) Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159: 896-901
11. Mogulkoc N, Brutsche MH, Bishop PW, Greaves SM, Horroks AW, Egan JJ (2001) Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med 42: 103-108
12. Hoffmeyer F, Hoeper MM, Spiekerkötter E, Harringer W, Haverich A, Fabel H, Niedermeyer J (2000) Azathioprine withdrawal in stable lung and heart/ lung recipients receiving cyclosporine-based immunosuppression. Transplantation 70: 522-525
13. Opelz O, Döhler B (2004) Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 4: 222-230
14. Herrera JM, McNeil KD (2001) Airway complications after lung transplantation: treatment and long-term outcome. Ann Thorac Surg 71: 989-994
15. Kennedy AS, Sonett JR (2000) High dose rate brachytherapy to prevent recurrent benign hyperplasia in lung transplant bronchi: theoretical and clinical considerations. J Heart Lung Transplant 19: 155-159
16. Seyedhossein Aharinejad S, Shahrokh Taghavi S, Walter Klepetko W, Abraham D (2004) Prediction of lung-transplant rejection by hepatocyte growth factor. Lancet 363: 1503-1508
17. Valentine VG, Taylor DE, Dhillon GS (2002) Success of lung transplantation without surveillance biopsy. J Heart Lung Transplant 21: 319-326
18. Gaspert A, Boehler A, Weder W, Speich R, Vogt P (2000) Spezielle Probleme nach Lungentransplantation: Eine Gratwanderung zwischen Infektion und Abstossungsreaktion. Schweiz Med Wochenschr 130: 944-951
19. Kotloff RM, Ahya VN, Stephen W, Crawford SW (2004) Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med 170: 22-48
20. Simonneau G, Galie N, Rubin LJ et al. (2004) Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43: S5-S12
21. Hoeper MM, Galie N, Simonneau G, Rubin LJ (2002) New treatments for pulmonary arterial hypertension. Am J Respir Crit Care Med 165: 1209-1216
22. Galie N, Seeger W, Naeije R, Simonneau G, Rubin LJ (2004) Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 43: S81-88
23. Hoeper MM, Krowka MJ, Strassburg CP (2004) Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 363: 1461-1468
24. Cahill BC, Somerville KT, Crompton JA, Parker ST, O'Rourke MK, Stringham JC, Karwande SV (2003) Early experience with sirolimus in lung transplant recipients with chronic allograft rejection. J Heart Lung Transplant 22: 169-176
25. Gerhardt SG, McDyer JF, Girgis RE, Conte JV, Stephen C, Yang SC, Orens JB (2003) Maintenance azithromycin therapy for branchiolitis obliterans syndrome results of a pilot study. Am J Respir Crit Care Med 168: 121-125
26. Verleden GM, Dupont LJ (2004) Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation.Transplantation 77: 1465-1467
27. Tegtbur U, Sievers C, Busse MW et al. (2004) Lebensqualität und körperliche Leistungsfähigkeit bei Patienten nach Lungentransplantation. Pneumologie 58: 72-78
28. Lands LC (1999) Maximal exercise capacity and peripheral skeletal muscle function following lung transplantation. J Heart Lung Transplant 18: 113-120